CD97 binds CD55

Stable Identifier
R-HSA-879674
Type
Reaction [binding]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

CD55 (or Decay Accelerating Factor; DAF) is a member of the regulators of complement activation (RCA) family. It protects host cells from complement system attack by binding to C3b and C4b preventing formation of the membrane attack complex. CD97 is a member of the Adhesion class or LNB subfamily of family B GPCRs, characterized by long N-terminal regions containing domains contain multiple tandem epidermal growth factor (EGF)-like repeats in their N-termini (Foord et al. 2002). CD97 is constitutively expressed on granulocytes and monocytes and is rapidly up-regulated on activated T and B cells. It is known to have many splice forms containing different numbers of EGF domains, consequently binding CD55 with differing affinities. The highest affinity variant has three EGF domains. The leukocyte-restricted expression pattern of CD97, and the presence of both CD97 and CD55 in arthritic joints suggest a possible role in adhesion and signaling within the inflammatory and immune responses (Lin et al. 2001).

Literature References
PubMed ID Title Journal Year
11297558 Molecular analysis of the epidermal growth factor-like short consensus repeat domain-mediated protein-protein interactions: dissection of the CD97-CD55 complex

Lin, HH, Stacey, M, Saxby, C, Knott, V, Chaudhry, Y, Evans, D, Gordon, S, McKnight, AJ, Handford, PA, Lea, S

J Biol Chem 2001
9064337 The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF)

Hamann, J, Vogel, B, van Schijndel, GM, van Lier, RA

J Exp Med 1996
Participants
Participates
Orthologous Events
Authored
Reviewed
Created
Cite Us!